The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Cell-Based Immunotherapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cell-Based Immunotherapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cell-Based Immunotherapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cell-Based Immunotherapy in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cell-Based Immunotherapy include Novartis, Gilead Sciences, AbbVie, Bristol-Myers Squibb, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim and Eli Lilly and Company, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell-Based Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell-Based Immunotherapy.
Report Scope
The Cell-Based Immunotherapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell-Based Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell-Based Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Novartis
- Gilead Sciences
- AbbVie
- Bristol-Myers Squibb
- Amgen
- AstraZeneca
- Biogen
- Boehringer Ingelheim
- Eli Lilly and Company
- GSK
- Pfizer
- Roche
- Takara Bio
- Bausch Health
- Apac Biotech
- Dendreon Pharmaceuticals (SanPower)
- JW CreaGene
- Green Cross Corp
Segment by Type
- Autologous Cellular Immunotherapy
- Chimeric Antigen Receptor (CAR) T-Cell Therapy
- Dendritic Cell-based Vaccine Therapy
Segment by Application
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell-Based Immunotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-Based Immunotherapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Autologous Cellular Immunotherapy
1.2.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy
1.2.4 Dendritic Cell-based Vaccine Therapy
1.3 Market by Application
1.3.1 Global Cell-Based Immunotherapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell-Based Immunotherapy Market Perspective (2019-2030)
2.2 Cell-Based Immunotherapy Growth Trends by Region
2.2.1 Global Cell-Based Immunotherapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell-Based Immunotherapy Historic Market Size by Region (2019-2024)
2.2.3 Cell-Based Immunotherapy Forecasted Market Size by Region (2025-2030)
2.3 Cell-Based Immunotherapy Market Dynamics
2.3.1 Cell-Based Immunotherapy Industry Trends
2.3.2 Cell-Based Immunotherapy Market Drivers
2.3.3 Cell-Based Immunotherapy Market Challenges
2.3.4 Cell-Based Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-Based Immunotherapy Players by Revenue
3.1.1 Global Top Cell-Based Immunotherapy Players by Revenue (2019-2024)
3.1.2 Global Cell-Based Immunotherapy Revenue Market Share by Players (2019-2024)
3.2 Global Cell-Based Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell-Based Immunotherapy Revenue
3.4 Global Cell-Based Immunotherapy Market Concentration Ratio
3.4.1 Global Cell-Based Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-Based Immunotherapy Revenue in 2023
3.5 Cell-Based Immunotherapy Key Players Head office and Area Served
3.6 Key Players Cell-Based Immunotherapy Product Solution and Service
3.7 Date of Enter into Cell-Based Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-Based Immunotherapy Breakdown Data by Type
4.1 Global Cell-Based Immunotherapy Historic Market Size by Type (2019-2024)
4.2 Global Cell-Based Immunotherapy Forecasted Market Size by Type (2025-2030)
5 Cell-Based Immunotherapy Breakdown Data by Application
5.1 Global Cell-Based Immunotherapy Historic Market Size by Application (2019-2024)
5.2 Global Cell-Based Immunotherapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell-Based Immunotherapy Market Size (2019-2030)
6.2 North America Cell-Based Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell-Based Immunotherapy Market Size by Country (2019-2024)
6.4 North America Cell-Based Immunotherapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell-Based Immunotherapy Market Size (2019-2030)
7.2 Europe Cell-Based Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell-Based Immunotherapy Market Size by Country (2019-2024)
7.4 Europe Cell-Based Immunotherapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell-Based Immunotherapy Market Size (2019-2030)
8.2 Asia-Pacific Cell-Based Immunotherapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell-Based Immunotherapy Market Size (2019-2030)
9.2 Latin America Cell-Based Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell-Based Immunotherapy Market Size by Country (2019-2024)
9.4 Latin America Cell-Based Immunotherapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-Based Immunotherapy Market Size (2019-2030)
10.2 Middle East & Africa Cell-Based Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Cell-Based Immunotherapy Introduction
11.1.4 Novartis Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Cell-Based Immunotherapy Introduction
11.2.4 Gilead Sciences Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.2.5 Gilead Sciences Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Cell-Based Immunotherapy Introduction
11.3.4 AbbVie Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.3.5 AbbVie Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Cell-Based Immunotherapy Introduction
11.4.4 Bristol-Myers Squibb Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Amgen
11.5.1 Amgen Company Detail
11.5.2 Amgen Business Overview
11.5.3 Amgen Cell-Based Immunotherapy Introduction
11.5.4 Amgen Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.5.5 Amgen Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Cell-Based Immunotherapy Introduction
11.6.4 AstraZeneca Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Biogen
11.7.1 Biogen Company Detail
11.7.2 Biogen Business Overview
11.7.3 Biogen Cell-Based Immunotherapy Introduction
11.7.4 Biogen Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.7.5 Biogen Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Detail
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Cell-Based Immunotherapy Introduction
11.8.4 Boehringer Ingelheim Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Detail
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Cell-Based Immunotherapy Introduction
11.9.4 Eli Lilly and Company Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.9.5 Eli Lilly and Company Recent Development
11.10 GSK
11.10.1 GSK Company Detail
11.10.2 GSK Business Overview
11.10.3 GSK Cell-Based Immunotherapy Introduction
11.10.4 GSK Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.10.5 GSK Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Detail
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Cell-Based Immunotherapy Introduction
11.11.4 Pfizer Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.11.5 Pfizer Recent Development
11.12 Roche
11.12.1 Roche Company Detail
11.12.2 Roche Business Overview
11.12.3 Roche Cell-Based Immunotherapy Introduction
11.12.4 Roche Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.12.5 Roche Recent Development
11.13 Takara Bio
11.13.1 Takara Bio Company Detail
11.13.2 Takara Bio Business Overview
11.13.3 Takara Bio Cell-Based Immunotherapy Introduction
11.13.4 Takara Bio Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.13.5 Takara Bio Recent Development
11.14 Bausch Health
11.14.1 Bausch Health Company Detail
11.14.2 Bausch Health Business Overview
11.14.3 Bausch Health Cell-Based Immunotherapy Introduction
11.14.4 Bausch Health Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.14.5 Bausch Health Recent Development
11.15 Apac Biotech
11.15.1 Apac Biotech Company Detail
11.15.2 Apac Biotech Business Overview
11.15.3 Apac Biotech Cell-Based Immunotherapy Introduction
11.15.4 Apac Biotech Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.15.5 Apac Biotech Recent Development
11.16 Dendreon Pharmaceuticals (SanPower)
11.16.1 Dendreon Pharmaceuticals (SanPower) Company Detail
11.16.2 Dendreon Pharmaceuticals (SanPower) Business Overview
11.16.3 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Introduction
11.16.4 Dendreon Pharmaceuticals (SanPower) Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.16.5 Dendreon Pharmaceuticals (SanPower) Recent Development
11.17 JW CreaGene
11.17.1 JW CreaGene Company Detail
11.17.2 JW CreaGene Business Overview
11.17.3 JW CreaGene Cell-Based Immunotherapy Introduction
11.17.4 JW CreaGene Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.17.5 JW CreaGene Recent Development
11.18 Green Cross Corp
11.18.1 Green Cross Corp Company Detail
11.18.2 Green Cross Corp Business Overview
11.18.3 Green Cross Corp Cell-Based Immunotherapy Introduction
11.18.4 Green Cross Corp Revenue in Cell-Based Immunotherapy Business (2019-2024)
11.18.5 Green Cross Corp Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Cell-Based Immunotherapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Autologous Cellular Immunotherapy
Table 3. Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Table 4. Key Players of Dendritic Cell-based Vaccine Therapy
Table 5. Global Cell-Based Immunotherapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Cell-Based Immunotherapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Cell-Based Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Cell-Based Immunotherapy Market Share by Region (2019-2024)
Table 9. Global Cell-Based Immunotherapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Cell-Based Immunotherapy Market Share by Region (2025-2030)
Table 11. Cell-Based Immunotherapy Market Trends
Table 12. Cell-Based Immunotherapy Market Drivers
Table 13. Cell-Based Immunotherapy Market Challenges
Table 14. Cell-Based Immunotherapy Market Restraints
Table 15. Global Cell-Based Immunotherapy Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Cell-Based Immunotherapy Market Share by Players (2019-2024)
Table 17. Global Top Cell-Based Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Based Immunotherapy as of 2023)
Table 18. Ranking of Global Top Cell-Based Immunotherapy Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Cell-Based Immunotherapy Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cell-Based Immunotherapy Product Solution and Service
Table 22. Date of Enter into Cell-Based Immunotherapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell-Based Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Cell-Based Immunotherapy Revenue Market Share by Type (2019-2024)
Table 26. Global Cell-Based Immunotherapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Cell-Based Immunotherapy Revenue Market Share by Type (2025-2030)
Table 28. Global Cell-Based Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Cell-Based Immunotherapy Revenue Market Share by Application (2019-2024)
Table 30. Global Cell-Based Immunotherapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Cell-Based Immunotherapy Revenue Market Share by Application (2025-2030)
Table 32. North America Cell-Based Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Cell-Based Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Cell-Based Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Cell-Based Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Cell-Based Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Cell-Based Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Cell-Based Immunotherapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Cell-Based Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Cell-Based Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Cell-Based Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Cell-Based Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 47. Novartis Company Detail
Table 48. Novartis Business Overview
Table 49. Novartis Cell-Based Immunotherapy Product
Table 50. Novartis Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 51. Novartis Recent Development
Table 52. Gilead Sciences Company Detail
Table 53. Gilead Sciences Business Overview
Table 54. Gilead Sciences Cell-Based Immunotherapy Product
Table 55. Gilead Sciences Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 56. Gilead Sciences Recent Development
Table 57. AbbVie Company Detail
Table 58. AbbVie Business Overview
Table 59. AbbVie Cell-Based Immunotherapy Product
Table 60. AbbVie Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 61. AbbVie Recent Development
Table 62. Bristol-Myers Squibb Company Detail
Table 63. Bristol-Myers Squibb Business Overview
Table 64. Bristol-Myers Squibb Cell-Based Immunotherapy Product
Table 65. Bristol-Myers Squibb Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 66. Bristol-Myers Squibb Recent Development
Table 67. Amgen Company Detail
Table 68. Amgen Business Overview
Table 69. Amgen Cell-Based Immunotherapy Product
Table 70. Amgen Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 71. Amgen Recent Development
Table 72. AstraZeneca Company Detail
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca Cell-Based Immunotherapy Product
Table 75. AstraZeneca Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 76. AstraZeneca Recent Development
Table 77. Biogen Company Detail
Table 78. Biogen Business Overview
Table 79. Biogen Cell-Based Immunotherapy Product
Table 80. Biogen Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 81. Biogen Recent Development
Table 82. Boehringer Ingelheim Company Detail
Table 83. Boehringer Ingelheim Business Overview
Table 84. Boehringer Ingelheim Cell-Based Immunotherapy Product
Table 85. Boehringer Ingelheim Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 86. Boehringer Ingelheim Recent Development
Table 87. Eli Lilly and Company Company Detail
Table 88. Eli Lilly and Company Business Overview
Table 89. Eli Lilly and Company Cell-Based Immunotherapy Product
Table 90. Eli Lilly and Company Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 91. Eli Lilly and Company Recent Development
Table 92. GSK Company Detail
Table 93. GSK Business Overview
Table 94. GSK Cell-Based Immunotherapy Product
Table 95. GSK Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 96. GSK Recent Development
Table 97. Pfizer Company Detail
Table 98. Pfizer Business Overview
Table 99. Pfizer Cell-Based Immunotherapy Product
Table 100. Pfizer Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 101. Pfizer Recent Development
Table 102. Roche Company Detail
Table 103. Roche Business Overview
Table 104. Roche Cell-Based Immunotherapy Product
Table 105. Roche Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 106. Roche Recent Development
Table 107. Takara Bio Company Detail
Table 108. Takara Bio Business Overview
Table 109. Takara Bio Cell-Based Immunotherapy Product
Table 110. Takara Bio Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 111. Takara Bio Recent Development
Table 112. Bausch Health Company Detail
Table 113. Bausch Health Business Overview
Table 114. Bausch Health Cell-Based Immunotherapy Product
Table 115. Bausch Health Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 116. Bausch Health Recent Development
Table 117. Apac Biotech Company Detail
Table 118. Apac Biotech Business Overview
Table 119. Apac Biotech Cell-Based Immunotherapy Product
Table 120. Apac Biotech Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 121. Apac Biotech Recent Development
Table 122. Dendreon Pharmaceuticals (SanPower) Company Detail
Table 123. Dendreon Pharmaceuticals (SanPower) Business Overview
Table 124. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product
Table 125. Dendreon Pharmaceuticals (SanPower) Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 126. Dendreon Pharmaceuticals (SanPower) Recent Development
Table 127. JW CreaGene Company Detail
Table 128. JW CreaGene Business Overview
Table 129. JW CreaGene Cell-Based Immunotherapy Product
Table 130. JW CreaGene Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 131. JW CreaGene Recent Development
Table 132. Green Cross Corp Company Detail
Table 133. Green Cross Corp Business Overview
Table 134. Green Cross Corp Cell-Based Immunotherapy Product
Table 135. Green Cross Corp Revenue in Cell-Based Immunotherapy Business (2019-2024) & (US$ Million)
Table 136. Green Cross Corp Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell-Based Immunotherapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cell-Based Immunotherapy Market Share by Type: 2023 VS 2030
Figure 3. Autologous Cellular Immunotherapy Features
Figure 4. Chimeric Antigen Receptor (CAR) T-Cell Therapy Features
Figure 5. Dendritic Cell-based Vaccine Therapy Features
Figure 6. Global Cell-Based Immunotherapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Cell-Based Immunotherapy Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Cell-Based Immunotherapy Report Years Considered
Figure 13. Global Cell-Based Immunotherapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Cell-Based Immunotherapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Cell-Based Immunotherapy Market Share by Region: 2023 VS 2030
Figure 16. Global Cell-Based Immunotherapy Market Share by Players in 2023
Figure 17. Global Top Cell-Based Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Based Immunotherapy as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Cell-Based Immunotherapy Revenue in 2023
Figure 19. North America Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Cell-Based Immunotherapy Market Share by Country (2019-2030)
Figure 21. United States Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Cell-Based Immunotherapy Market Share by Country (2019-2030)
Figure 25. Germany Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Cell-Based Immunotherapy Market Share by Region (2019-2030)
Figure 33. China Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Cell-Based Immunotherapy Market Share by Country (2019-2030)
Figure 41. Mexico Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Cell-Based Immunotherapy Market Share by Country (2019-2030)
Figure 45. Turkey Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Cell-Based Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Novartis Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 48. Gilead Sciences Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 49. AbbVie Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 51. Amgen Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 52. AstraZeneca Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 53. Biogen Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 54. Boehringer Ingelheim Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 55. Eli Lilly and Company Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 56. GSK Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 57. Pfizer Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 58. Roche Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 59. Takara Bio Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 60. Bausch Health Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 61. Apac Biotech Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 62. Dendreon Pharmaceuticals (SanPower) Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 63. JW CreaGene Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 64. Green Cross Corp Revenue Growth Rate in Cell-Based Immunotherapy Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
